Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center Open Label, Non-comparative Observational Study of Irbesartan-Hydrochlorothiazide in the Treatment of Hypertension in Chinese Population

NCT00847834 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00847834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00847834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center Open Label, Non-comparative Observational Study of Irbesartan-Hydrochlorothiazide in the Treatment of Hypertension in Chinese Population
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2003
Completion date
Not reported
Enrollment
968 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension